Business
Trade Spotlight: How should you trade Ajanta Pharma, HFCL, Timken India, Linde India, Supreme Industries, and others on March 13?
Trade Spotlight: How should you trade Ajanta Pharma, HFCL, Timken India, Linde India, Supreme Industries, and others on March 13?

About this update from Timken India Limited
The benchmark indices remained under pressure for another session, falling nearly 1 percent on March 12 following a rise in oil prices amid Strait of Hormuz tensions. The market breadth was favourable for bears as about 1,920 shares declined against 1,034 rising shares on the NSE. The market is expected to continue to face risk-off sentiment amid geopolitical tensions. Below are some short-term trading ideas to consider:Jay Mehta, Technical Research at JM Financial ServicesAjanta Pharma | CMP: Rs 3,119.5Ajanta Pharma has decisively broken out above the long-standing resistance zone of Rs 3,020–3,080, which has been in place since October 2024. Over the last four sessions, volume has consistently exceeded average levels, reflecting strong participation and genuine buying interest.The price now trades comfortably above all key EMAs, with upward-sloping averages. Momentum indicators remain in bullish territory, and trend indicators suggest the bullish move is likely to continue. The structure favours buyers while the breakout zone holds.Strategy: BuyTarget: Rs 3,381, Rs 3,450Stop-Loss: Rs 2,945HFCL | CMP: Rs 74.47HFCL has formed a clear double-bottom bullish reversal pattern (highlighted in yellow). Post-breakout, the price re-entered the pattern and formed a bullish tweezer bottom at the key support of Rs 64.5. Volume has increased over the past four consecutive sessions and the stock trades above moving averages.The price sits above the 20- and 50-day EMAs and is attempting to reclaim the 200-day EMA. Momentum indicators are in bullish territory, and trend indicators point to continued upside potential.Strategy: BuyTarget: Rs 79, Rs 83.3Stop-Loss: Rs 69.5Timken India | CMP: Rs 3,486.5Timken India broke out above a key resistance trendline on February 25. Since then, the price has hovered around the trendline and the 20-day EMA as support. Recent sessions show strong positive traction, with volume rising above average levels.The price trades above all key EMAs with upward slopes. Momentum indicators remain in bullish territory, and trend indicators indicate the bullish trend is likely to persist.Strategy: BuyTarget: Rs 3,685, Rs 3,800Stop-Loss: Rs 3,200Aakash Shah, Research Analyst at Choice BrokingLinde India | CMP: Rs 7,189.5Linde India is displaying a strong bullish continuation setup on the daily chart after spending the past few weeks in a consolidatio...
View stock analysis, news, and events for Timken India Limited